Determination of switching dose from preexisting ESAs to epoetin beta pegol in peritoneal dialysis patients.

Determination of switching dose from preexisting ESAs to epoetin beta pegol in peritoneal dialysis patients. - Determination of efficacy of epoetin beta pegol in peritoneal dialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000006813

Enrollment

100

Registered

2011-12-12

Start date

2011-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia with chronic kidney disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: anemia with chronic kidney disease 20 years old or more Written consent of study participation

Exclusion criteria

Exclusion criteria: The case whom physician think that the patient should not participate in this study. A patient who has cancer. A patient who has active gastrointestinal bleeding.

Design outcomes

Primary

Measure	Time frame
Kidney survival rate	—

Secondary

Measure	Time frame
Target achievement rate of anemia correction	—

Countries

Japan

Contacts

Public ContactNoriaki Iino

Niigata University Graduate School of Medical and Dental Sciences Division of Clinical Nephrology and Rheumatology

niino@med.niigata-u.ac.jp025-227-2200

Outcome results